Clinical Trials Browser

HER-2 Negatived Gastric Cancer × apatinib × Clear all

NCT03950141 2019-05-15

Apatinib Combined With S-1 as Maintenance Therapy for HER-2 Negatived Gastric Cancer

Phase 2 Unknown

Gastrointestinal

HER-2 Negatived Gastric Cancer